KLRSKalaris Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Kalaris Therapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KLRS본 종목 | $48M#7 | — | 0.8x#4 | 288.5x#5 | — | 37.2%#1 | -27970.9%#6 | -75.3%#6 | — | — | — | — |
| CRDF | $66M#1 | — | 2.5x#9 | 112.0x#4 | -13.2%#3 | -0.9%#5 | -8256.3%#4 | -0.2%#1 | — | — | — | — |
| CGTX | $65M#2 | — | 2.0x#8 | — | — | 30.9%#2 | — | -71.1%#5 | — | — | — | — |
| INKT | $55M#3 | — | — | — | — | -15.9%#8 | — | — | — | — | — | — |
| BKHAU | $54M#4 | — | — | — | — | -30.6%#10 | — | — | — | — | — | 94.1%#1 |
| ELOX | $53M#5 | 3.7x#2 | 1.1x#5 | — | -100.0%#5 | -90.7%#13 | — | -12.9%#2 | — | — | — | — |
| CRBU | $48M#6 | — | 0.5x#3 | 4.3x#2 | 11.7%#2 | 0.7%#4 | -1329.4%#2 | -151.0%#7 | — | — | — | — |
| LONA | $47M#8 | — | 1.4x#6 | — | — | -9.3%#6 | — | -315.5%#10 | — | — | — | — |
| TIL | $47M#9 | — | 0.4x#2 | — | -100.0%#5 | 3.7%#3 | — | -66.5%#4 | — | — | — | — |
| IMA | $47M#10 | — | 0.3x#1 | 58.2x#3 | -77.1%#4 | -24.0%#9 | -6056.4%#3 | -31.9%#3 | — | — | -52.3%#1 | — |
| PTHS | $42M#11 | — | — | 2.5x#1 | — | -444.6%#15 | -193.1%#1 | — | — | — | — | — |
| TVGN | $41M#12 | — | — | — | — | -91.4%#14 | — | — | — | — | -79.7%#3 | — |
| EXOZ | $40M#13 | — | 11.1x#10 | 577.5x#6 | — | -56.3%#12 | -13867.0%#5 | -250.6%#9 | — | — | -61.0%#2 | — |
| INMB | $38M#14 | — | 1.9x#7 | 768.8x#7 | 257.1%#1 | -9.5%#7 | -94766.0%#7 | -225.9%#8 | -607.3%#1 | — | — | — |
| IRLA | $33M#15 | 0.3x#1 | — | — | — | -47.8%#11 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice